开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2023-06-27 ms8000001312073437 来自甘肃省

偏重的研究方向：内分泌
经验分享：请问这个收meta分析嘛？

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2021-06-03 ariiiii

审稿速度:2.0
偏重的研究方向：内分泌 ; 代谢
经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！

115 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2023-05-17 ms9000000658400380 来自广东省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：内分泌
经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2022-08-22 miamatsuoka

偏重的研究方向：内分泌
经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！

79 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2021-11-28 wkw0722

今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀

85 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2022-05-18 ms9000001057878125

这个杂志的投稿状态会发生变化吗？是一直是under review？

77 0

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2022-05-15 ms7000001991487882

请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家

78 0

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2022-03-15 ms1000000859956723

网状Meta分析要吗

88 0

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2019-04-02 ms4512939187244456

under riview已经两个月了

180 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2145005, encodeId=37752145005e7, content=偏重的研究方向：内分泌 经验分享：请问这个收meta分析嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30218761848, createdName=ms8000001312073437, createdTime=Tue Jun 27 11:51:50 CST 2023, time=2023-06-27, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=970615, encodeId=27349e061593, content=审稿速度:2.0 偏重的研究方向：内分泌 ; 代谢 经验分享：去年5月份底投稿review，按照编辑的要求格式稍作修改后送审。七月中旬一审返回，主编回信附上审稿人意见和修改意见，8月底修改完后返回，中间可能期刊官网出了点问题，编辑那块没有收到我的稿件。10月多我又重新提交了一次很快接收，当天就在pubmed在线发表！编辑非常nice,审稿人提的意见都很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/a02d4141a67044e18d5ba02f8c9c618f/68c065ee0e484f3f865de362423d025a.jpg, createdBy=e40f5323086, createdName=ariiiii, createdTime=Thu Jun 03 16:22:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2136243, encodeId=7a8f2136243d2, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：投稿1个月给大修意见，修回不到一个月给小修，小修修回10天接收；效率还是很高的。大修审稿人的意见还是很细的，不错的杂志，投稿体验满分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3538238455, createdName=ms9000000658400380, createdTime=Wed May 17 00:29:23 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240372, encodeId=2e4a12403e272, content=偏重的研究方向：内分泌 经验分享：各位小伙伴，千万不要看到ps那里not assigned就撤稿…这个杂志好像并没有ps…… 我的文章是在ps not assigned的状态under review并且真的送审了，现在已经大修修回来了，整个修稿期一直都是ps not assigned的状态，如果还有哪位遇到这种情况，安静等待就好了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=253c2135983, createdName=miamatsuoka, createdTime=Mon Aug 22 21:52:33 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074717, encodeId=7e9110e4717bb, content=今年有在这个杂志投稿的吗？从投稿到一审回来大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun Nov 28 09:48:29 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220648, encodeId=536e122064894, content=这个杂志的投稿状态会发生变化吗？是一直是under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Wed May 18 13:26:51 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219812, encodeId=edec121981222, content=请问大家，research 类型的文章中，引文网址怎么搞啊？尤其Google scholar没法登录啊。较急，在线等，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa06425319, createdName=ms7000001991487882, createdTime=Sun May 15 19:05:26 CST 2022, time=2022-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202859, encodeId=db39120285911, content=网状Meta分析要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f646473920, createdName=ms1000000859956723, createdTime=Tue Mar 15 19:32:33 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850592, encodeId=9acc850592bf, content=under riview已经两个月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e295414102, createdName=ms4512939187244456, createdTime=Tue Apr 02 08:01:25 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580172, encodeId=3aa55801e2fb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：大修一次小修一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74242313996, createdName=miyo8888, createdTime=Wed Nov 20 18:10:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]

2019-11-20 miyo8888

审稿速度:3.0 | 投稿命中率:50.0
经验分享：大修一次小修一次

178 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务